M.G. Natchus
Procter and Gamble Pharmaceuticals
8700 Mason-Montgomery Road
Mason
Ohio 45040
USA
Name/email consistency: high
- Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines. Natchus, M.G., Bookland, R.G., Laufersweiler, M.J., Pikul, S., Almstead, N.G., De, B., Janusz, M.J., Hsieh, L.C., Gu, F., Pokross, M.E., Patel, V.S., Garver, S.M., Peng, S.X., Branch, T.M., King, S.L., Baker, T.R., Foltz, D.J., Mieling, G.E. J. Med. Chem. (2001)
- Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines. Natchus, M.G., Bookland, R.G., De, B., Almstead, N.G., Pikul, S., Janusz, M.J., Heitmeyer, S.A., Hookfin, E.B., Hsieh, L.C., Dowty, M.E., Dietsch, C.R., Patel, V.S., Garver, S.M., Gu, F., Pokross, M.E., Mieling, G.E., Baker, T.R., Foltz, D.J., Peng, S.X., Bornes, D.M., Strojnowski, M.J., Taiwo, Y.O. J. Med. Chem. (2000)